Strict glycaemic control in diabetic patients with CKD or ESRD: beneficial or deadly?
Schernthaner
Guntram
G
Department of Medicine I, Rudolfstiftung Hospital, Vienna, Austria. guntram.schernthaner@wienkav.at
Ritz
Eberhard
E
Schernthaner
Gerit-Holger
GH
D001786:Blood Glucose / Q000378:metabolism; D002908:Chronic Disease; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000401:mortality* / Q000628:therapy; D007676:Kidney Failure, Chronic / Q000401:mortality* / Q000628:therapy; D006435:Renal Dialysis; D015996:Survival Rate
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents